Hengdi Pharmaceutical: Passed the on-site inspection by the US FDA.

Hubei Hendi Pharmaceutical Co., Ltd. underwent an on-site inspection by the U.S. Food and Drug Administration's CGMP daily supervision from November 10th to 14th, 2025. The company recently received the on-site inspection report issued by the FDA and, in accordance with the regulations of the U.S. 21CFR, the FDA confirmed that the inspection has concluded, and the company passed the on-site inspection.